Literature DB >> 31289044

Prenatal bed rest in developed and developing regions: a systematic review and meta-analysis.

Brittany Matenchuk1, Rshmi Khurana1, Chenxi Cai1, Normand G Boulé1, Linda Slater1, Margie H Davenport2.   

Abstract

BACKGROUND: Bed rest is prescribed by most maternity health care professionals for high-risk pregnancy complications, but the impact of bed rest at home and in hospital has not been explored. Our aim was to quantify the influence of bed rest on maternal/fetal health outcomes in developed and developing regions.
METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials. We conducted a structured search through MEDLINE, Embase, CINAHL, Web of Science and the Cochrane Library through Mar. 7, 2019. Trials comparing standard care to standard care plus bed rest after 20 weeks' gestation were assessed. Outcomes included infant birth weight, being small for gestational age, gestational age, premature or very premature birth, perinatal death, admission to the neonatal intensive care unit, preterm rupture of membranes, hypertensive disorders of pregnancy, preeclampsia and gestational diabetes mellitus.
RESULTS: We identified 1191 publications, of which 43 were assessed for eligibility. Sixteen publications reporting on 14 unique studies (2608 women, 3328 infants) were included in the analysis. Overall, maternal/newborn outcomes were similar between women on bed rest and those not on bed rest. In subgroup analyses of developed and developing regions, length of gestation was shorter with bed rest (weighted mean difference -0.77 wk, 95% confidence interval [CI] -1.26 to -0.27, I 2 = 0%), and the risk of a very premature birth was increased (risk ratio 2.07, 95% CI 1.15 to 3.73, I 2 = 0%) in developed countries.
INTERPRETATION: In developed regions, treatment of complicated pregnancies with more than 1 week of bed rest results in worse newborn outcomes. Additional studies are required to determine whether bed rest or hospital admission improves outcomes in developing regions. PROSPERO Trial registration number: CRD42018099237. Copyright 2019, Joule Inc. or its licensors.

Entities:  

Year:  2019        PMID: 31289044      PMCID: PMC6620175          DOI: 10.9778/cmajo.20190014

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  2 in total

1.  Physical Activity Behaviors and Barriers in Multifetal Pregnancy: What to Expect When You're Expecting More.

Authors:  Victoria L Meah; Morgan C Strynadka; Rshmi Khurana; Margie H Davenport
Journal:  Int J Environ Res Public Health       Date:  2021-04-08       Impact factor: 3.390

2.  Cost-effectiveness of cervical length screening and progesterone treatment to prevent spontaneous preterm delivery in Sweden.

Authors:  U-B Wennerholm; L Valentin; T Wikström; P Kuusela; B Jacobsson; H Hagberg; P Lindgren; M Svensson
Journal:  Ultrasound Obstet Gynecol       Date:  2022-06       Impact factor: 8.678

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.